About This Project
The high specificity and sensitivity of the CRISPR diagnostics, e.g. SHERLOCK, can detect the presence of the pathogen genome and report out the result accurately through the CRISPR-Cas system. It provides genome targeting based results and is superior to any serological based rapid test kits (RTKs). This project aims to improve the CRISPR diagnostic platform with an amplification-free approach, to enable a novel and robust RTK for SARS-COV2 detection.
Recent Lab Notes From This Project
Browse Other Projects on Experiment
Due to increasing reliance on grain as a source of carbohydrates, shortages can occur if supply is interrupted...
Chernobyl’s Legacy: Does radiation exposure affect parasite and disease rates in two of Chernobyl's carnivores?
Radioactive material released by the Chernobyl accident is claimed to have created one of the largest ecological...